Ligand Pharmaceuticals Incorporated Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 AKRO
|
Akero Therapeutics, Inc. | $32.72 | $1.59 B | -7.1 | 61 | $0 |
 ANNX
|
Annexon, Inc. | $7.25 | $523.15 M | -3.93 | 71 | $0 |
 APLS
|
Apellis Pharmaceuticals, Inc. | $28.08 | $4.90 B | -11.77 | 702 | $396.59 M |
 ASND
|
Ascendis Pharma A/S | $128.27 | $7.77 B | -14.19 | 879 | $266.72 M |
 BGNE
|
BeiGene, Ltd. | $208.02 | $17.07 B | -20.76 | 10000 | $2.46 B |
 BPMC
|
Blueprint Medicines Corporation | $97.56 | $6.47 B | -21.48 | 638 | $249.38 M |
 CGEM
|
Cullinan Oncology, Inc. | $15.98 | $1.29 B | -7.16 | 85 | $0 |
|
CRNX
|
Crinetics Pharmaceuticals, Inc. | $57.88 | $3.53 B | -11.86 | 290 | $4.01 M |
 CYTK
|
Cytokinetics, Incorporated | $52.57 | $6.05 B | -9.78 | 423 | $7.53 M |
 DSGN
|
Design Therapeutics, Inc. | $5.55 | $217.51 M | -3.7 | 57 | $0 |
 ETNB
|
89bio, Inc. | $9.23 | $796.91 M | -4.05 | 70 | $0 |
 GPCR
|
Structure Therapeutics Inc. | $39.28 | $2.47 B | -23.59 | 136 | $0 |
 ICVX
|
Icosavax, Inc. | $15.31 | $769.04 M | -6.96 | 60 | $582,000 |
 LYEL
|
Lyell Immunopharma, Inc. | $1.24 | $619.50 M | -2.7 | 224 | $130,000 |
 ORIC
|
ORIC Pharmaceuticals, Inc. | $9.66 | $595.34 M | -4.91 | 107 | $0 |
 PASG
|
Passage Bio, Inc. | $0.64 | $73.04 M | -0.77 | 58 | $0 |
 RCUS
|
Arcus Biosciences, Inc. | $15.29 | $1.41 B | -4.98 | 577 | $117.00 M |
 RLAY
|
Relay Therapeutics, Inc. | $5.95 | $1.05 B | -3 | 304 | $25.55 M |
 TERN
|
Terns Pharmaceuticals, Inc. | $7.17 | $462.44 M | -5.67 | 66 | $0 |
 VRDN
|
Viridian Therapeutics, Inc. | $23.31 | $776.72 M | -2.71 | 94 | $314,000 |